Pancreatic Cancer Research

ResearcherAir Force Medical UniversityActive in the last 2 years

Yupeng Di

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1635-8918; OpenAlex author ID A5103270169. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2025: 1 paper · 2026: 3 papers

Papers 4

  1. Ablative ultra-hypofractionated radiotherapy with surgical GI exclusion as a "functional spacer" for pancreatic cancer: a phase I safety and feasibility study. Co-author DOI 10.1186/s12885-026-16358-8↗
  2. Baseline and dynamic neutrophil-to-lymphocyte ratio predicts overall survival in unresectable pancreatic cancer following dose-escalated SBRT: a ten-year longi… Co-author DOI 10.3389/fmolb.2026.1877894↗
  3. Case Report: Exceptional long-term survival in metastatic pancreatic ductal adenocarcinoma after repeated high-dose hypofractionated lesion-directed radiothera… Co-author DOI 10.3389/fonc.2026.1897746↗
  4. Metabolic reprogramming and prognostic modeling in pancreatic cancer: insights from WGCNA. Co-author DOI 10.3389/fgene.2025.1487046↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gang Ren · 2 shared papers, 2025–2026 · strength 0.67
  2. Gan Ren · 1 shared paper, 2026 · strength 0.43
  3. Lingling Meng · 1 shared paper, 2026 · strength 0.43
  4. M C Ding · 1 shared paper, 2026 · strength 0.39
  5. Yingjie Wang · 1 shared paper, 2025 · strength 0.28
  6. Zhuo Song · 1 shared paper, 2025 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.